Pascal Chiari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pascal Chiari has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Jean-Luc Fellahi
Service d'Anesthésie-Réanimation, Hôpital Louis Pradel, Hospices Civils de Lyon and the Inserm U1060, Laboratoire CarMeN, IHU OPeRa, Lyon, France
2 shared publications- Michel Durand
Pole d'Anesthésie-Réanimation, Hôpital Albert Michallon, Centre Hospitalier Universitaire de Grenoble-Alpes, Grenoble, France
2 shared publications Michel Ovize
Inserm U1060, Laboratoire CarMeN, IHU OPeRa, Lyon, France.; Centre d'Investigation Clinique de Lyon (CIC 1407 Inserm), Hospices Civils de Lyon, Lyon, France
2 shared publicationsAbdallah Gharib
INSERM UMR 1060, CarMeN laboratory, Université Lyon 1, IHU OPERA, Hôpital Louis Pradel, Hospices Civils de Lyon, F-69677 Lyon, France
1 shared publicationArnaud Ferraris
Service d'Anesthésie-Réanimation, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France
1 shared publication- Bernadette Vaz
Centre d'Investigation Clinique de Lyon (CIC 1407 Inserm), Hospices Civils de Lyon, Lyon, France
1 shared publication
Latest Publications
- 9 December 2023
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (3) , 857-859
The ProCCard Study: Clinical Study Design Compared With Experimental Conditions
- 9 December 2023
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (3) , 857-859
The ProCCard Study: Clinical Study Design Compared With Experimental Conditions
- 14 April 2023
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 37 (8) , 1368-1376
A Multimodal Cardioprotection Strategy During Cardiac Surgery: The ProCCard Study
- 14 April 2023
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 37 (8) , 1368-1376
A Multimodal Cardioprotection Strategy During Cardiac Surgery: The ProCCard Study
- Open Access
- 1 October 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (42) , 15282-15292
A modified calcium retention capacity assay clarifies the roles of extra- and intracellular calcium pools in mitochondrial permeability transition pore opening
- 1 October 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (42) , 15282-15292
Open AccessA modified calcium retention capacity assay clarifies the roles of extra- and intracellular calcium pools in mitochondrial permeability transition pore opening
- Open Access
- 11 September 2019
- Published by Springer Nature in Trials
- Vol. 20 (1) , 1-9
Multimodal cardioprotective strategy in cardiac surgery (the ProCCard trial): Study protocol for a multicenter randomized controlled trial
Background: Myocardial damage in patients undergoing cardiac surgery increases both morbidity and mortality. Different protective strategies dealing with either preconditioning or postconditioning or assessing a single aspect of cardioprotection have shown conflicting results. We tested the hypothesis that a multimodal approach would improve cardioprotection and limit myocardial damage following cardiac surgery with cardiopulmonary bypass. Methods: This study is a pragmatic multicenter (six French institutions), prospective, randomized, single-blinded, controlled trial. The randomization is stratified by centers. In the study, 210 patients scheduled for aortic valve surgery with or without coronary artery bypass grafting will be assigned to a control or a treatment group (105 patients in each group). In the control group, patients receive total intravenous anesthesia with propofol and liberal intraoperative blood glucose management (initiation of insulin infusion when blood glucose, measured every 60 min, is greater than 180 mg/dl), as a standard of care. The treatment group receives a bundle of care combining five techniques of cardioprotection: (1) remote ischemic preconditioning applied before aortic cross-clamping; (2) maintenance of anesthesia with sevoflurane; (3) tight intraoperative blood glucose management (initiation of insulin infusion when blood glucose, measured every 30 min, is greater than 140 mg/dl); (4) moderate respiratory acidosis (pH 7.30) at the end of cardiopulmonary bypass; and (5) a gentle reperfusion protocol following aortic unclamping. The primary outcome is myocardial damage measured by postoperative 72-h area under the curve of high-sensitivity cardiac troponin I. Discussion: The ProCCard study will be the first multicenter randomized controlled trial aiming to assess the role of a bundle of care combining several cardioprotective strategies to reduce myocardial damage in patients undergoing cardiac surgery with cardiopulmonary bypass. Trial registration: ClinicalTrials.gov, NCT03230136. Registered on July 26, 2017. Last updated on April 17, 2019.
- 11 September 2019
- Published by Springer Nature in Trials
- Vol. 20 (1) , 1-9
Open AccessMultimodal cardioprotective strategy in cardiac surgery (the ProCCard trial): Study protocol for a multicenter randomized controlled trial
Background: Myocardial damage in patients undergoing cardiac surgery increases both morbidity and mortality. Different protective strategies dealing with either preconditioning or postconditioning or assessing a single aspect of cardioprotection have shown conflicting results. We tested the hypothesis that a multimodal approach would improve cardioprotection and limit myocardial damage following cardiac surgery with cardiopulmonary bypass. Methods: This study is a pragmatic multicenter (six French institutions), prospective, randomized, single-blinded, controlled trial. The randomization is stratified by centers. In the study, 210 patients scheduled for aortic valve surgery with or without coronary artery bypass grafting will be assigned to a control or a treatment group (105 patients in each group). In the control group, patients receive total intravenous anesthesia with propofol and liberal intraoperative blood glucose management (initiation of insulin infusion when blood glucose, measured every 60 min, is greater than 180 mg/dl), as a standard of care. The treatment group receives a bundle of care combining five techniques of cardioprotection: (1) remote ischemic preconditioning applied before aortic cross-clamping; (2) maintenance of anesthesia with sevoflurane; (3) tight intraoperative blood glucose management (initiation of insulin infusion when blood glucose, measured every 30 min, is greater than 140 mg/dl); (4) moderate respiratory acidosis (pH 7.30) at the end of cardiopulmonary bypass; and (5) a gentle reperfusion protocol following aortic unclamping. The primary outcome is myocardial damage measured by postoperative 72-h area under the curve of high-sensitivity cardiac troponin I. Discussion: The ProCCard study will be the first multicenter randomized controlled trial aiming to assess the role of a bundle of care combining several cardioprotective strategies to reduce myocardial damage in patients undergoing cardiac surgery with cardiopulmonary bypass. Trial registration: ClinicalTrials.gov, NCT03230136. Registered on July 26, 2017. Last updated on April 17, 2019.
- 29 August 2017
- Published by Springer Nature
- p. 453-467
Ischemia-Reperfusion Concepts of Myocardial Preconditioning and Postconditioning
- 29 August 2017
- Published by Springer Nature
- p. 453-467
Ischemia-Reperfusion Concepts of Myocardial Preconditioning and Postconditioning